Immunology
Conference Coverage
What happens when a baked egg oral challenge is negative?
How do you help patients with egg allergy?
Conference Coverage
Uptick found in severe allergy shot reactions
ATLANTA – There has been an uptick in reports of severe grade 4 reactions to subcutaneous allergen immunotherapy for reasons that are not yet...
From the Journals
Lanadelumab reduced hereditary angioedema attacks by 88%-100%
Lanadelumab reduced attacks of hereditary angioedema with C1 inhibitor deficiency by 88%-100%.
From the Journals
Adverse event reporting in second-dose varicella vaccination shows no surprises
No new or unexpected adverse events were reported in association with second-dose varicella vaccination in children age 4-18 years.
News
Children having an anaphylactic attack at school may not get proper treatment
Children experiencing an anaphylactic event at school may frequently encounter staff members who are not permitted to administer potentially life-...
News
New-onset pediatric AD phenotype differs from adult AD
The skin phenotype of new-onset pediatric atopic dermatitis differs substantially from that in adult AD, which has important therapeutic...
News
EpiPen cost increases far exceed overall medical inflation
Total Medicare part D spending on EpiPen auto-injectors rose from $7.0 million in 2007 to $87.9 million in 2014, according to the Kaiser Family...
News
When should primary care physicians prescribe antibiotics to children with respiratory infection symptoms?
Younger patients with shorter illness durations who presented with wheeze, fever, vomiting, intercostal or subcostal recession, and/or asthma were...
News
Mylan’s generic EpiPen – a price break or marketing maneuver?
News
Peanut-allergic preschoolers benefit from oral immunotherapy
Early intervention oral immunotherapy (OIT) improved a majority of peanut-allergic preschoolers’ ability to eat peanut protein with no reaction....
Conference Coverage
Nonpharmacologic AD therapy: Strongest evidence supports moisturizers
BOSTON – Moisturizers are “a cornerstone” of therapy for children with atopic dermatitis.